Trial
NCT01434745
SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Oregon Health and Science University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Smith-Lemli-Opitz Syndrome
Intervention
Simvastatin
Why stopped
poor enrollment (only one subject enrolled)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-01